Advertisement Press Releases Archive - Page 108 of 233 - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Pressreleases

  • BioBLU® Family Grows: New 1 L Single-Use Bioreactor for Cell Culture and Microbial Applications

    At this year's BIOTECHNICA in Hannover, Germany Eppendorf has presented the newest members of its single-use bioreactor family BioBLU for the first time. With the new single-use bioreactor BioBLU 1c for cell culture and BioBLU 1f for microbial applications Eppendorf further extends its portfolio of rigid wall single-use bioreactors. These 1 L vessels are bridging the gap between the BioBLU 0.3 c/f mini single-use bioreactors and the larger vessels of the BioBLU family.

  • Eppendorf® Introduces a Single-Use Bioreactor for Microbial Applications

    With the introduction of the new BioBLU® 0.3f, Eppendorf® offers for the first time a fully-instrumented single-use bioreactor designed specifically for microbial applications. The BioBLU 0.3f joins the BioBLU 0.3c which was presented last year and is designed for the cultivation of animal and human cells. Both the BioBLU 0.3c and BioBLU 0.3f are specifically designed for use with the compact DASbox® mini bioreactor system. Eppendorf's DASbox system is a unique mini bioreactor system for parallel operation of 4, 8 or more mini-bioreactors and well suited for Design of Experiment (DoE), bioprocess development screening and for use as a scale-down model.

  • Malvern Zetasizer APS Delivers Unattended Protein Screening for Medicon Valley’s SARomics Biostructures

    An automated dynamic light scattering system from Malvern Instruments has become established as an essential part of the analytical toolkit used by SARomics Biostructures AB, a leading provider of protein 3D structure determination and structure-based drug design services. The Zetasizer APS automated plate sampling system is supporting the systematic study of the aggregation behavior of proteins, a fundamental component of the services provided by SARomics Biostructures. The company, which is based in Lund, Sweden within the biotech cluster of the Medicon Valley, is a research-intensive organisation with clients around the world.

  • Johnson Matthey Acquires Pharmaceutical Manufacturing Capacity in Scotland

    Johnson Matthey, a leading provider of pharmaceutical services, active pharmaceutical ingredients (APIs) and catalyst technologies, has announced completion of an acquisition of pharmaceutical manufacturing capacity in Scotland, U.K. The 109,000 sq. metre site was acquired to meet increasing demand for custom pharmaceutical services and active ingredients utilising enhanced manufacturing capabilities.